INFLUENZA UPDATE 2011-2012 DEBBYE ROSEN ADULT IMMUNIZATION COORDINATOR CONNECTICUT DEPARTMENT OF PUBLIC HEALTH 860-509-7729 1.

Slides:

Advertisements

Similar presentations

FLU SEASON IMPORTANT FACTS.

Advertisements

Influenza Vaccine Considerations Season

1 ACIP Influenza Vaccine Recommendations Season Carolyn B. Bridges, MD, FACP Associate Director of Adult Immunizations ISD, NCIRD, CDC National.

Lisa Grohskopf, MD, MPH Influenza Division, NCIRD, CDC ACIP Influenza Vaccine Recommendations Season National Center for Immunization & Respiratory.

Vaccines and Related Biological Products Advisory Committee 18 February 2009 Topic 2: Considerations and Implications for adding two B Strains to the Seasonal.

Liza Chapman, Pharm.D. GPhA Annual Meeting

Vaccine Update and Refresher for Immunizations: 2012 Krista D. Capehart, PharmD, MSPharm, AE-C David G. Bowyer, R. Ph. Assistant Professors of Pharmacy.

Vaccines and Related Biological Products

1 Alberta’s Influenza Immunization Program TARRANT Workshop Elaine Sartison AHW March

Introduction Director’ s Welcom e INFLUENZA Department of Defense Seasonal Influenza Vaccination Program Leaders Briefing UNCLASSIFIED.

Administration by Emergency Medical Services Personnel

INFLUENZA VACCINE CONSIDERATIONS SEASON Alicia Vanden Bosch, PharmD Creighton University SPAHP September,

Tonya Philbrick, BS, NCMA Director

Adult Immunization 2010 Hepatitis A Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

Influenza and Influenza Vaccine

Influenza Annual Training Health, healing and hope.

September 11, 2014 Cindy Schulte, RN, BSN Kathy Sen, RN, BSN Vaccine Preventable Disease Surveillance Bureau of Immunization New York State Department.

Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.

Immunization Update Andrew Kroger, MD, MPH National Center for Immunization and Respiratory Diseases Andrew Kroger, MD, MPH National Center for Immunization.

INFLUENZA (FLU) Management Presentation

Influenza Prevention We anticipate that there will be two types of influenza illness and two different types of influenza vaccine this year Seasonal influenza.

Influenza (The Flu).

2012–2013 Influenza Season Epidemiology Lynn Sosa, MD Deputy State Epidemiologist Connecticut Department of Public Health 1.

Community pharmacy flu vaccination services- preparing for 2014/15.

“Prevent all the Disease You Can… Then Treat the Rest.”

Influenza Vaccination

Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.

1 Adult Immunization Update Iyabode A. Beysolow, M.D., M.P.H. National Center for Immunization and Respiratory Diseases NC Immunization Conference Greensboro,

Making Sense of New Vaccine Recommendations Vermont Immunization Conference Stowe, Vermont October 28, 2011 Vermont Immunization Conference Stowe, Vermont.

INFLUENZA VACCINE Group 1 Zainab Ashfaq Bushra Abbas Ahtasham Danish.

UNDERLYING SOCIOECONOMIC, CULTURAL, POLITICAL AND ENVIRONMENTAL DETERMINANTS Globalization Urbanization Population NON MODIFIABLE.

Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.

Connecticut Immunization Hot Topics Teleconference Series September 2011 NANCY FENLON, RN, MS CDC National Center for Immunization and Respiratory Diseases.

1 Making Sense of New Vaccine Recommendations Vermont Immunization Conference Stowe, Vermont October 28, 2011 William Atkinson, MD, MPH National Center.

Title page Influenza and Older Adults COM R.

VRBPAC 25 February 2011 Influenza Vaccine Manufacturing Industry Perspective for Vaccine Supply.

Kenneth McCall, BSPharm, PharmD Associate Professor | UNE.

Introduction Director’ s Welcom e INFLUENZA Department of Defense Influenza Vaccination Program Briefing UNCLASSIFIED.

Influenza Update September 2015

Influenza and Influenza Vaccines K. Vahdat 25/11/1391.

Texas Immunization Branch Influenza Update July 24 th, 2008.

Influenza Vaccine Supply : Issues and Opportunities Raymond A. Strikas, M.D. National Immunization Program Coordinating Center for Infectious Diseases.

1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.

Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (Q-Pan H5N1 Vaccine) Manufactured by GlaxoSmithKline Vaccines and Related Biological Products Advisory.

FDA/CBER Vaccines and Related biological Products Advisory Committee Meeting Discussion of Clinical Trials to Support use of Vaccines against the 2009.

Influenza A (H1N1) Vaccine Vaccines and Related Biological Products Advisory Committee Meeting, 23 July 2009 Raburn Mallory, M.D. Proprietary Vaccines.

Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Influenza Vaccine Segment Graphics subject to change. This material in the public domain.

- 1 - H1N1 Influenza What we know What is H1N1 Flu? A new, or novel, flu for which humans have little or no natural immunity H1N1 has been declared.

What Is H1N1 (Swine Flu) Pandemic Influenza? Colorized image of H1N1 from a transmission electron micrograph. Source: CDC.

Troi Cunningham, RN Kentucky Immunization Program October 2015.

Update from the 2010 National Influenza Vaccine Summit meeting L.J Tan Co-chair, National Influenza Vaccine Summit Director, Medicine and Public Health,

Kenneth McCall, BSPharm, PharmD Associate Professor | UNE.

8/18/09 Novel A (H1NI) Influenza Vaccination August 18, 2009 Massachusetts Department of Public Health.

September 16, 2014 Bedford Senior Center Joyce Cheng RN Community Health Nurse Bedford Board of Health.

1 Influenza Vaccination 2016 Cluster: Communicable Disease, NDoH.

Tammra L. Morrison, RN Communicable Disease Coordinator Christopher J. Smith, RS, MPA Director of Environmental Health Rodney Dancy Community Preparedness.

INFLUENZA AND INFECTIOUS DISEASE FORUM JULY 29, 2010 ERIN BACHUS, ADULT IMMUNIZATION COORDINATOR COMMUNICABLE DISEASE CONTROL AND PREVENTION SAN FRANCISCO.

Ocean State Immunization Collaborative 2016 State - Supplied Vaccine Workshop May 17, 2016.

Carol Friedman, D.O. Associate Director for Adult Immunization Immunization Services Division National Center for Immunization and Respiratory Diseases.

*Facility ID:*Event #: *Patient ID:Social Security #: Secondary ID: Patient Name, Last: First: Middle: *Gender: F M Other *Date of Birth: Ethnicity (specify):Race.

2007 National Health Policy Conference Preparing to Protect: Flu Vaccines from Production to Consumption A Public Health Perspective Daniel Hopfensperger.

ACIP Recommendations Update for the U.S. Influenza Season

Influenza Vaccines Immunization Update: Maine Pharmacy Association

Welcome! Thank you for joining the American College of Physicians’ Quality Connect Adult Immunization Learning Series Webinar! We will start in a few.

Immunization Update Call 7/9/2013

Immunization FaQs 2018 Amy Bachyrycz.

DSHS Adult Vaccine Program

Seasonal Flu & the H1N1 Virus What you need to know!

Influenza Experience: Highlights and Comments

GP PLT: Community Paediatrics

Presentation transcript:

INFLUENZA UPDATE DEBBYE ROSEN ADULT IMMUNIZATION COORDINATOR CONNECTICUT DEPARTMENT OF PUBLIC HEALTH

2 EARLY RELEASE AUGUST 18, RECOMMENDATIONS

ACIP Vaccination of all persons aged ≥6 months (adopted in 2010) continues to be recommended Vaccine virus strains for 2011–2012 Vaccination schedule for children aged 6 months through 8 years Considerations regarding vaccination of persons with egg allergy A new formulation of trivalent inactivated vaccine that is given intradermally (into the skin) 3

WHO YOU SHOULD VACCINATE 160 MILLION DOSES WILL BE AVAILABLE > 6 MONTHS OF AGE AT RISK POPULATIONS HEART DISEASE, COPD AND OTHER CHRONIC RESPIRATORY ILLNESSES, DIABETES PREGNANT VACCINATE AS SOON AS VACCINE IS AVAILABLE 4

Vaccine strains for –A/California/7/2009-like H1N1 –A/Perth/16/2009-like H3N2 –B/Brisbane/60/2008 5

6 CHILDREN 6 MONTHS - 8 YEARS CHILDREN IN THIS AGE GROUP RECEIVING VACCINE FOR THE FIRST TIME OR WITH UNKNOWN VACCINE HISTORY SHOULD RECEIVE 2 DOSES CHILDREN IN THIS AGE GROUP WHO RECEIVED AT LEAST 1 DOSE OF SEASONAL VACCINE WILL REQUIRE ONLY ONE DOSE OF SEASONAL VACCINE CHILDREN IN THIS AGE GROUP WHO DID NOT RECEIVE AT LEAST ONE DOSE OF VACCINE OR FOR WHOM IT IS NOT CERTAIN WHETHER THE DOSE WAS RECEIVED, SHOULD RECEIVE 2 DOSES

7 CHILDREN 6 MONTHS- 8 YEARS

EGG ALLERGY 8

Product NameAge IndicationManufactured by Fluarix> 3 years of ageGlaxoSmithKline FluLaval>18 years of ageID Biomedical Corporation Fluvirin> 4 years of ageNovartis Agriflu> 18 years of ageNovartis Afluria> 5 years of age * CSL Limited (Merck) Fluzone> 6 months of ageSanofi Pasteur High dose Fluzone> 65 years of ageSanofi Pasteur Intradermal Fluzone18 years-64 years of age Sanofi Pasteur FluMist-nasal2 years-64 years ** MedImmune * In the US not recommended for children 5-8yrs ** healthy INFLUENZA VACCINE PRODUCTS 9

10

INTRADERMAL INFLUENZA VACCINE 11

INTRADERMAL VACCINE ADMINISTRATION 12

13

14

LEARN MORE ABOUT IT

INFLUENZA UPDATE DEBBYE ROSEN ADULT IMMUNIZATION COORDINATOR CONNECTICUT DEPARTMENT OF PUBLIC HEALTH ?????????????????????????????????????????